In addition, RKIP can indirectly modulate tumor suppressors such as the p53/p21Cip1/Rb axis by inhibiting the Raf/MEK/ERK signaling cascade, which is required to suppress this axis by blocking p53 acetylation at K161/162 [164]. The gene discussed is MAPK1; the disease is neoplasm.